Beta-glucans for Hospitalised Patients With COVID-19
Clinical trial NCT05465798 · UNKNOWN
Trial details
- NCT number
- NCT05465798
- Sponsor
- Wohlstand Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.